肠道病毒组定植的嗜肝病毒属与溃疡性结肠炎发病机制相关,并在体内诱导肠道炎症
该研究探讨了嗜肝病毒属编码的乙型肝炎病毒X蛋白(HBx)在溃疡性结肠炎(UC)发病中的作用。约45%的UC患者可检测到HBx,HBx可在小鼠中诱导结肠炎症,而沉默HBx可逆转体内结肠炎表型;HBx作为上皮细胞转录调节因子,导致屏障渗漏并改变黏膜免疫。结论认为HBx是UC发病的促进因素,病毒组可作为个体化治疗的靶点。
要点
- 约45%的UC患者可检测到HBx,HBx可在小鼠中诱导结肠炎症。
- 沉默HBx可逆转体内结肠炎表型。
- HBx作为上皮细胞转录调节因子,导致屏障渗漏并改变黏膜免疫。
核心结论
- 本研究将HBx描述为UC发病机制的促进因素,并为病毒组作为个体化治疗靶点提供了新视角。
研究设计与样本
- 研究通过RT-PCR和Sanger测序评估UC患者来源血液和肠道黏膜的HBx阳性,并用多因素分析其与临床特征的相关性。
- 对健康供者内镜活检组织进行HBx过表达的转录组学分析;C57BL/6小鼠接受脂质体偶联的HBx编码质粒或对照的黏膜内注射,伴或不伴抗生素治疗。
- 对HBx处理组和对照组动物的结肠样本进行多维流式细胞术分析;在体外肠道屏障模型中进行了跨上皮电阻测量、增殖实验、染色质免疫沉淀测序和RNA测序;在体外和体内进行了HBx沉默实验。
主要发现
- 约45%的UC患者可检测到HBx,且HBx可在小鼠中诱导结肠炎症,而沉默HBx可逆转体内结肠炎表型。
- HBx在上皮细胞中作为转录调节因子,在体外和体内导致屏障渗漏并改变先天性和适应性黏膜免疫。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Ulcerative colitis (UC) is a chronic inflammatory disorder of unknown aetiology. Gut virome dysbiosis is fundamental in UC progression, although its role in the early phases of the disease is far from fully understood. Therefore, we sought to investigate the role of a virome-associated protein encoded by the Orthohepadnavirus genus, the hepatitis B virus X protein (HBx), in UC aetiopathogenesis. DESIGN: HBx positivity of UC patient-derived blood and gut mucosa was assessed by RT-PCR and Sanger sequencing and correlated with clinical characteristics by multivariate analysis. Transcriptomics was performed on HBx-overexpressing endoscopic biopsies from healthy donors.C57BL/6 mice underwent intramucosal injections of liposome-conjugated HBx-encoding plasmids or the control, with or without antibiotic treatment. Multidimensional flow cytometry analysis was performed on colonic samples from HBx-treated and control animals. Transepithelial electrical resistance measurement, proliferation assay, chromatin immunoprecipitation assay with sequencing and RNA-sequencing were performed on in vitro models of the gut barrier. HBx-silencing experiments were performed in vitro and in vivo. RESULTS: HBx was detected in about 45% of patients with UC and found to induce colonic inflammation in mice, while its silencing reverted the colitis phenotype in vivo. HBx acted as a transcriptional regulator in epithelial cells, provoking barrier leakage and altering both innate and adaptive mucosal immunity ex vivo and in vivo. CONCLUSION: This study described HBx as a contributor to the UC pathogenesis and provides a new perspective on the virome as a target for tailored treatments.
引用
- Massimino L, Palmieri O, Facoetti A, et al. Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo. Gut. 2023. PMID: 36788014. doi:10.1136/gutjnl-2022-328375
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。